Literature DB >> 28305962

Heart targeting of retroviral expression in avian embryos: a species-independent phenomenon.

I Hlozanek1, D Luton1, F Dieterlen-Lièvre1, T Jaffredo1.   

Abstract

A replication-incompetent retroviral vector derived from spleen necrosis virus (SNV), in which the viral structural genes gag, pol, and env were replaced with the bacterial β-galactosidase gene lacZ, was used to infect embryos from outbred and inbred chicken lines, japanese quail and duck between embryonic day 0 and 13. LacZ expression was restricted to a few organs or cell types, and this distribution was not influenced by the different routes of inoculation tested but was specified by the age of the embryo at the time of inoculation. Inoculations at E0-E1 beneath or onto the blastodisc resulted in lacZ expression in ectodermal derivatives, i.e. skin and neural structures. From E2 onwards, heart muscle and skin were the preferential targets in all the species or inbred lines tested. Heart muscle was positive in 100% of the embryos displaying lacZ+ clones. Skin exhibited on and off periods depending on the age at inoculation. No lacZ-positive clones were detected in chick embryos infected after Ell. Outbred chick embryos displayed the largest array of organs labelled (heart, skin, liver, gizzard) while quail and duck embryos exhibited a more restrictive pattern. These results are of import if the vector is to be used as a tool to map lineages or to transfer genes into the developing embryo.

Entities:  

Keywords:  Avian development; Heart; Viral vectors

Year:  1995        PMID: 28305962     DOI: 10.1007/BF00241275

Source DB:  PubMed          Journal:  Rouxs Arch Dev Biol        ISSN: 0930-035X


  28 in total

1.  Amino-terminal amino acid sequence of the major structural polypeptides of avian retroviruses: sequence homology between reticuloendotheliosis virus p30 and p30s of mammalian retroviruses.

Authors:  E Hunter; A S Bhown; J C Bennett
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

2.  A series of normal stages in the development of the chick embryo.

Authors:  V HAMBURGER; H L HAMILTON
Journal:  J Morphol       Date:  1951-01       Impact factor: 1.804

3.  Radial arrangement of clonally related cells in the chicken optic tectum: lineage analysis with a recombinant retrovirus.

Authors:  G E Gray; J C Glover; J Majors; J R Sanes
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

4.  Ectopic expression of genes during chicken limb pattern formation using replication defective retroviral vectors.

Authors:  J L de la Pompa; R Zeller
Journal:  Mech Dev       Date:  1993-10       Impact factor: 1.882

5.  Continuous tissue culture cell lines derived from chemically induced tumors of Japanese quail.

Authors:  C Moscovici; M G Moscovici; H Jimenez; M M Lai; M J Hayman; P K Vogt
Journal:  Cell       Date:  1977-05       Impact factor: 41.582

6.  Replication-competent retroviral vectors encoding alkaline phosphatase reveal spatial restriction of viral gene expression/transduction in the chick embryo.

Authors:  D M Fekete; C L Cepko
Journal:  Mol Cell Biol       Date:  1993-04       Impact factor: 4.272

Review 7.  Prague inbred lines of chickens: a biological model for MHC research.

Authors:  J Plachý; M Vilhelmová; I Karakoz; J Schulmannová
Journal:  Folia Biol (Praha)       Date:  1989       Impact factor: 0.906

8.  Construction of a helper cell line for avian reticuloendotheliosis virus cloning vectors.

Authors:  S Watanabe; H M Temin
Journal:  Mol Cell Biol       Date:  1983-12       Impact factor: 4.272

9.  Targets of v-myc tumorigenesis in the avian embryo depend on time and not on site of retroviral infection.

Authors:  A E al Moustafa; M B Raes; S Saule; F Dieterlen-Lièvre
Journal:  Cell Differ Dev       Date:  1988-11

10.  Metanephric mesenchyme contains multipotent stem cells whose fate is restricted after induction.

Authors:  D Herzlinger; C Koseki; T Mikawa; Q al-Awqati
Journal:  Development       Date:  1992-03       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.